These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31877115)

  • 1. MetAP2 inhibition reduces food intake and body weight in a ciliopathy mouse model of obesity.
    Pottorf TS; Fagan MP; Burkey BF; Cho DJ; Vath JE; Tran PV
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of intraflagellar transport-A causes hyperphagia-induced obesity and metabolic syndrome.
    Jacobs DT; Silva LM; Allard BA; Schonfeld MP; Chatterjee A; Talbott GC; Beier DR; Tran PV
    Dis Model Mech; 2016 Jul; 9(7):789-98. PubMed ID: 27482817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors.
    Farrell PJ; Zopf CJ; Huang HJ; Balakrishna D; Holub C; Bilakovics J; Fanjul A; Matuszkiewicz J; Plonowski A; Rolzin P; Banerjee U; Ermolieff J; Cheruvallath ZS; McBride C; Bartkowski D; Mazur C; Pachori A; Larson CJ
    J Pharmacol Exp Ther; 2019 Nov; 371(2):299-308. PubMed ID: 31537613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraflagellar-transport A dysfunction causes hyperphagia-induced systemic insulin resistance in a pre-obese state.
    Jacobs DT; Allard BA; Pottorf TS; Silva LM; Wang W; Al-Naamani A; Agborbesong E; Wang T; Carr DA; Tran PV
    FASEB J; 2020 Jan; 34(1):148-160. PubMed ID: 31914634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
    PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice.
    Sheng X; Wang M; Lu M; Xi B; Sheng H; Zang YQ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E886-93. PubMed ID: 21364120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilia signaling and obesity.
    Engle SE; Bansal R; Antonellis PJ; Berbari NF
    Semin Cell Dev Biol; 2021 Feb; 110():43-50. PubMed ID: 32466971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
    Yu XX; Murray SF; Watts L; Booten SL; Tokorcheck J; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E436-45. PubMed ID: 18523126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term feeding at the wrong time is sufficient to desynchronize peripheral clocks and induce obesity with hyperphagia, physical inactivity and metabolic disorders in mice.
    Yasumoto Y; Hashimoto C; Nakao R; Yamazaki H; Hiroyama H; Nemoto T; Yamamoto S; Sakurai M; Oike H; Wada N; Yoshida-Noro C; Oishi K
    Metabolism; 2016 May; 65(5):714-727. PubMed ID: 27085778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
    Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
    Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.
    Langeveld M; van den Berg SA; Bijl N; Bijland S; van Roomen CP; Houben-Weerts JH; Ottenhoff R; Houten SM; van Dijk KW; Romijn JA; Groen AK; Aerts JM; Voshol PJ
    Metabolism; 2012 Jan; 61(1):99-107. PubMed ID: 21816446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust Reductions of Excess Weight and Hyperphagia by Beloranib in Rat Models of Genetic and Hypothalamic Obesity.
    Elfers CT; Roth CL
    Endocrinology; 2017 Jan; 158(1):41-55. PubMed ID: 27849360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.
    Schwartz MW; Baskin DG; Bukowski TR; Kuijper JL; Foster D; Lasser G; Prunkard DE; Porte D; Woods SC; Seeley RJ; Weigle DS
    Diabetes; 1996 Apr; 45(4):531-5. PubMed ID: 8603777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin resistance is a secondary consequence of the obesity in ciliopathy mutant mice.
    Berbari NF; Pasek RC; Malarkey EB; Yazdi SM; McNair AD; Lewis WR; Nagy TR; Kesterson RA; Yoder BK
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7796-801. PubMed ID: 23599282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential and genetically separable associations of leptin with obesity-related traits.
    Thorburn AW; Holdsworth A; Proietto J; Morahan G
    Int J Obes Relat Metab Disord; 2000 Jun; 24(6):742-50. PubMed ID: 10878681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TrkB agonists ameliorate obesity and associated metabolic conditions in mice.
    Tsao D; Thomsen HK; Chou J; Stratton J; Hagen M; Loo C; Garcia C; Sloane DL; Rosenthal A; Lin JC
    Endocrinology; 2008 Mar; 149(3):1038-48. PubMed ID: 18063676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.